Free Initial Consultation
Toll Free:
defective drug attorneys st louis

St. Louis Pharmaceutical Blog

Risperdal Use Linked to Diabetes

One troubling side effect of Risperdal is that it may increase the patient’s risk of diabetes. This risk is associated with another common side effect of Risperdal: weight gain. The combination of weight gain and Risperdal use can lead to a frightening mixture.
Among the litany of startling side effects, diabetes is especially troubling. The use of Risperdal perhaps accentuates the otherwise undiagnosed diabetic symptoms in the patient, but diagnosed or not, diabetes can be fatal.
Usually the most prevalent symptoms of diabetes are increased levels of thirst and frequent urination, unintended weight loss, constant fatigue, digestive issues, tingling sensation in the feet, slow healing cuts and bruises, and vision problems. If left undiagnosed, diabetes can lead to heart disease, nerve damage, stroke, and eventual blindness.
If you or a loved one are experiencing any of these symptoms, contact your family physician as soon as possible.

Risperdal Associated With Male Breast Development

Of the known physical side effects associated with Risperdal, there is one of which that is especially troubling for men.  The condition is known as gynecomastia and it relates to the growth of breasts by men who have taken the drug.  The development of male breasts can be exceptionally frustrating and cause a great deal of distress.
Multiple suits have been filed against Janssen Pharmaceuticals, Inc. and a recent study Dr. Mahyar Etminan from the The University of British Columbia concluded that men who had used Risperdal or a variant of the drug had a 69% elevated risk of developing gynecomastia.  Also, patients using Risperdal had a significantly greater risk of developing gynecomastia, as opposed to those who had used an alternate means of medication.  Dr. Etminan was quoted as saying there, “is a strong association between the use of Risperdal and gynecomastia.

Risperdal Side Effects From USA

Risperdal is a very dangerous prescription drug.  It was used to treat any manner of psychological disorders and has since been at the center of attention for many class action law suits.  The side effects that the drug induced is long and rather varied, but here is a shortened list.  For the complete listing please follow the link to the National Institutes of Health website.
If you have experienced any of these side effects as a result of Risperdal use, contact The Roberts Law Firm today for more information at 636-530-9199.

Pradaxa Lawsuits filed in federal court are consolidated into Multidistrict Litigation (MDL)

Pradaxa® lawsuits filed in federal court are consolidated into a Multidistrict Litigation (MDL) in the US District Court for the Southern District of Illinois. District Judge David Herndon is the Judge presiding over the MDL. As reported by The Madison-St. Clair Record on October 5, 2012 Judge Herndon set a schedule for four “bellwether” trials that would start in August 2014 and end in early 2015. Also reported by The Madison-St. Clair Record on January 10, 2013 Judge Herndon said attorney’s are well into the Discovery Phase with each side producing various documents “by the tens of thousands” and that they will begin to take depositions of people with Boehringer Ingelheim Pharmaceuticals.

Tags: , ,

Patients using GranuFlo® and NaturaLyte® have suffered from cardiac arrest

GranuFlo® and NaturaLyte® have been prescribed for patients suffering from dialysis. Patients using these drugs have suffered from cardiac arrest. Plaintiffs filing lawsuits are alleging that the manufacturer knew of risks caused by the products prior to issuing warnings. Many individual cases have been filed but the courts are presently considering the site for a MDL (Multidistrict Litigation) to consolidate the filing of these cases in one place in Federal Court.

Tags: , ,

Baby Motrin drops recalled after plastic particles found

St. Louis area parents look to doctors and pharmaceutical companies as valuable partners in their effort to keep their babies and children healthy. Most of the time, parents are able to purchase medicines or other products that aid in their children’s well-being with no concerns at all. However, other times, problems can happen and sometimes when least expected. The importance of drug safety or the communication about drug recalls cannot be underestimated as vital elements of public health.
Nearly 200,000 0.5-ounce bottles of Concentrated Motrin Infants’ Drops Original Berry Flavor are being voluntarily recalled by the manufacturer due to the possibility that small plastic particles may be in the bottles. Such particles were found in some containers that had not yet been dispersed to the public at the McNeil Consumer Healthcare unit, a division of the pharmaceutical company Johnson & Johnson.
The plastic pieces are reported to be roughly the side of poppy seeds.


Recent verdict marks second win for plaintiffs in Fosamax cases

Osteoporosis is a disease that impacts an individual’s bones and bone density. Individuals diagnosed with osteoporosis are at an increased risk for suffering bone fractures and other health problems that may result from necessary surgeries to repair such fractures. In an effort to slow or prevent additional bone density loss associated with osteoporosis, many individuals take prescription medications.
The prescription drug Fosamax is one such drug commonly prescribed to combat the ill-effects associated with osteoporosis. For years, patients have reported possible dangerous side effects associated with use of Fosamax and there are currently more than 4,000 lawsuits pending against the drug’s maker Merck & Co. Inc.
The lawsuits contend the drug maker failed to adequately warn patients of potential dangerous side effects and risks associated with taking Fosamax.

Tags: , , ,

Birth control pills subject of nearly 10,000 lawsuits

Birth control pills subject of nearly 10,000 lawsuits
On behalf of Greg Roberts of The Roberts Law Firm, P.C. posted in Defective Drugs on Tuesday, September 10, 2013.
Oral contraceptives are extremely commonly prescribed and typically considered to be safe for use. For decades, women in St. Louis and around the country have counted on these medications for birth control as well as hormonal balancing. Despite the list of precautions and potential side effects listed, much of the time, birth control pills are able to be taken and used without problem.
Unfortunately, that is not always the case. Bayer Pharmaceuticals, the maker of two brands of oral contraceptives that are currently the subject of multiple lawsuits, faces a continued string of such suits. Statistics estimate that there are roughly 10,000 cases nationwide claiming that Yaz and Yasmin are essentially defective drugs, causing a host of physical problems for the women who take them.


Hospital simplifies management of recalled drugs

The U.S. Food and Drug Administration works to oversee all prescription medications and either issue or encourage manufacturers to issue recalls in the event a problem is identified. A recalled drug not promptly taken off of the market and prevented from getting to patients can lead to serious results from a drug injury to wrongful death. St. Louis area residents may not always know if they have been given a defective drug before it is too late.
With people’s lives literally on the line, one hospital decided to take strong action to help them keep pace with the FDA’s issuing of drug recalls. A new system utilizing Radio Frequency Identification technology allows all medications to be scanned into a system and easily tracked when needed. In a hospital setting, the pharmacy is not the only place that a medication may be when a recall is learned about.


FDA drug monitoring and reporting under scrutiny

The regulation of medications, both prescription and over-the-counter, is led by the United States Food and Drug Administration. The goal of the FDA’s programs is to ensure public health and safety by preventing defective drugs from either reaching the marketplace or from being further utilized if already being sold and taken. St. Louis citizens trust the FDA every day to be their eyes and ears and prevent harmful drugs from being on the market.
A recently published article discusses the FDA’s process for monitoring drugs and alerting the public about a drug recall. It is rare that the FDA actually issues or requires a recall of any drug. Rather, the safety regulation of pharmaceuticals works by notification to the manufacturer of an identified problem. At that point, any recall issued is done so at the discretion of the pharmaceutical company and is voluntary.


Privacy Policy | Business Development Solutions by FindLaw, a Thomson Reuters business.